Results 161 to 170 of about 125,713 (396)

Donor chimerism and bcr-abl gene status following non-myeloablative peripheral blood stem cell transplantation in chronic myeloid leukaemia patients in HUKM [PDF]

, 2008
Objective: This study was done to determine the relationship between donor chimerism and the presence of bcr-abl gene in chronic myeloid leukaemia (CML) patients post-transplantation.
Cheong, Soon Keng, Hussin, Noor Hamidah, Leong, Chooi Fun, Othman, Ainoon, Seman, Zainina   +4 more
core  

Strategies For Targeting Chronic Myeloid Leukaemia Stem Cells

Blood and Lymphatic Cancer: Targets and Therapy, 2019
Giovanna Carrà, Antonio Cartellà, Beatrice Maffeo, Alessandro Morotti Department Of Clinical And Biological Sciences, University Of Turin, Orbassano 10043, ItalyCorrespondence: Alessandro MorottiDepartment Of Clinical And Biological ...
Carrà G, Cartellà A, Maffeo B, Morotti A   +3 more
doaj  

Interphase cytogenetics and competitive RT‐PCR for residual disease monitoring in patients with chronic myeloid leukaemia during interferon‐α therapy [PDF]

, 1998
Andréï Tchirkov, M. Giollant, F Tavernier, G. Briançon, Olivier Tournilhac, Fabrice Kwiatkowski, Pierre Philippe, Bachra Choufi, François Deméocq, Philippe Travade, P Malet   +10 more
openalex   +1 more source

α₄β₁ integrin‐mediated adhesion of CD34⁺ cells from patients with chronic myeloid leukaemia: influence of IL‐3 [PDF]

, 1999
K. P. Schofield, Jan Duerig, G. Rushton, James Chang   +3 more
openalex   +1 more source

Haematopoietic stem cell transplantation for patients with myelo‐dysplastic syndromes and secondary acute myeloid leukaemias: a report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT) [PDF]

, 2000
Théo de Witte, J. Hermans, Jaak M. Vossen, Andrea Bacigalupo, Giovanna Meloni, N Jacobsen, Tapani Ruutu, Per Ljungman, Aloïs Gratwohl, Volker Runde, Dietger Niederwieser, Anja van Biezen, Agnès Devergie, Jan J. Cornelissen, Jean‐Pierre Jouet, Renate Arnold, Jane F. Apperley   +16 more
openalex   +1 more source

Therapeutic targeting of myeloid cells in liver fibrosis: Mechanisms and clinical prospects

Animal Models and Experimental Medicine, EarlyView.
This review systematically summarizes the origin, recruitment, and differentiation regulation mechanisms of myeloid cells in driving hepatic fibrosis progression. By targeting these three critical phases, potential therapeutic strategies for liver fibrosis can be explored.
Yue Wang, Yiming Liu, Dan Chen, Leiming Liu, Leimin Sun, Lingling Zhang   +5 more
wiley   +1 more source

Progress in Biomimetic Microdevices for Anticancer Drug Screening and their Potential for Enhancing In Vivo Efficacy

Advanced NanoBiomed Research, EarlyView.
Biomimetic microdevices are redefining anticancer drug screening by mimicking complex tumor microenvironments. This review highlights advances in microfluidic systems, cell microarrays, and in vivo‐like models, offering new insights into drug efficacy prediction and personalized medicine. The development of effective anticancer drugs remains a critical
Ching‐Te Kuo, Yen‐Tzu Liao, Hsinyu Lee   +2 more
wiley   +1 more source

Suppression of proline-directed protein kinase FAexpression inhibits the growth of human chronic myeloid leukaemia cells [PDF]

, 2000
Hsu Cp, Hsueh Sf, Yang Cc, Yang Sd
openalex   +1 more source

Dose‐reduced conditioning for allografting in 44 patients with chronic myeloid leukaemia: a retrospective analysis [PDF]

, 2001
Martin Bornhäuser, Michael Kiehl, W. Siegert, Johannes Schetelig, Bernd Hertenstein, Hans Martin, Rainer Schwerdtfeger, Herbert G. Sayer, Volker Runde, Nicolaus Kröger, Catrin Theuser, G. Ehninger   +11 more
openalex   +1 more source

Artificial intelligence modelling of tyrosine kinase inhibitors at risk of malabsorption and bioavailability‐enhancing strategies

British Journal of Clinical Pharmacology, EarlyView.
Aims The study aims to predict and improve the absorption of tyrosine kinase inhibitors (TKIs) in patients with malabsorption issues, particularly those who have undergone bariatric surgery or are using proton‐pump inhibitors. The research involves 2 main components: the development of an artificial intelligence (AI) model to identify TKIs that are ...
Daan W. Huntjens, Olivier J. M. Béquignon, Stefanie D. Krens, Mark Löwenberg, Martine E. D. Chamuleau, Remco J. Molenaar, Anita M. G. Kramers, Marianne A. Kuijvenhoven, Imke H. Bartelink   +8 more
wiley   +1 more source